Delivering therapy to target: improving the odds for successful drug development

Area of Science:

• Biomedical Engineering
• Pharmacology
• Medical Imaging

Background:

• Direct drug delivery into tissues is explored for various diseases, including brain cancer and neurodegenerative disorders.
• Clinical efficacy of direct drug delivery is critically dependent on achieving adequate distribution to the target site.
• Conventional imaging techniques fail to capture the complex drug transport pathways within tissues, potentially masking drug inefficacy as poor distribution.

Purpose of the Study:

• To highlight the importance of adequate drug delivery for clinical efficacy in targeted therapies.
• To discuss the limitations of current imaging in assessing drug distribution.
• To propose an integrated approach combining advanced imaging, simulations, and device design for improved therapeutic outcomes.

Main Methods:

• Reviewing existing evidence on direct drug delivery and its challenges.
• Discussing the complexity and diversity of drug transport pathways in tissues.
• Proposing the use of quantitative and real-time imaging for assessing drug distribution.
• Advocating for customized simulations based on imaging data.
• Emphasizing the role of optimized drug-device combinations.

Main Results:

• Inadequate drug delivery can lead to misinterpretation of therapeutic effectiveness.
• Current imaging methods do not adequately represent the intricate nature of drug transport in tissues.
• An integrated approach can potentially accelerate development and enhance patient treatment.

Conclusions:

• Optimizing drug distribution is paramount for the success of direct drug delivery therapies.
• Quantitative, real-time imaging and personalized simulations are essential for understanding and improving drug transport.
• Tailored drug-device designs are necessary to maximize therapeutic impact in targeted drug delivery.